$PROK
ProKidney Corp. Class A Ordinary Shares
XNAS•Health Care•Biological Products, (No Diagnostic Substances)
$1.58
▼-1.25%-$0.020
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateProKidney Corp. Class A Ordinary Shares
XNAS•Health Care•Biological Products, (No Diagnostic Substances)
Why is PROK down today? It is at $1.58 (-1.25%), and our scanner flagged it 64 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment PROK spikes, and full due diligence on PROK — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $PROK 64 times in the last 30 days. Create a free account to track $PROK, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
PROK is one of today's most active names, trading on unusually heavy volume (live price and day move above). Our scanner has fired 1 unusual-volume and momentum alert on PROK today, peaking at 3.3x its normal volume.
Likely catalystProKidney Reports Second Quarter 2026 Financial Results and Business HighlightsReported Ended Q2 2026 with $181.6 million in cash and cash equivalents and marketable securities, supporting operations into mid-2027Reported Liquidity: Cash, cash equivalents and marketable securities as of June 30, 2026, totaled $181.6 million, compared to $224.9 million as of March 31, 2026.Reported Net Loss Before Noncontrolling Interest: Net loss before noncontrolling interest was $46.4 million and $37.0 million for the three months ended June 30, 2026 and 2025, respectively., from an SEC filing. Read it →Latest filing4Insider trade (Form 4)Aug 20, 2026 · 48 days agoSources: float & market cap via Polygon · short interest via FINRA · borrow & shortability via Alpaca · SSR from Reg SHO 201 · filings & dilution via SEC EDGAR · analysts via Nasdaq.
Auto-generated from public data for research and education. Not investment advice.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Pereira Brian Jg Director | Sold (automatic/other) | -223K 0.1% of company | n/a | n/a | $317K at $1.42 | Aug 20, 26 |
Pereira Brian Jg Director | Sold (automatic/other) | -27K 0.01% of company | n/a | n/a | $38K at $1.42 | Aug 20, 26 |
Pereira Brian Jg Director | Sold (automatic/other) | -223K 0.1% of company | sold 50% | 223K | $321K at $1.44 | Aug 19, 26 |
Pereira Brian Jg Director | Sold (automatic/other) | -27K 0.01% of company | sold 50% | 27K | $39K at $1.44 | Aug 19, 26 |
Pereira Brian Jg Director | Sold (automatic/other) | -229K 0.1% of company | sold 34% | 446K | $314K at $1.37 | Aug 18, 26 |
Pereira Brian Jg Director | Sold (automatic/other) | -28K 0.01% of company | sold 34% | 54K | $38K at $1.37 | Aug 18, 26 |
Pereira Brian Jg Director | Acquired (grant/award) | +82K 0.04% of company | n/a | 82K | n/a | Aug 4, 26 |
Pereira Brian Jg Director | Acquired (grant/award) | +675K 0.3% of company | n/a | 675K | n/a | Aug 4, 26 |
Girolamo Todd C Officer | Acquired (grant/award) | +164K 0.08% of company | added 100% | 328K | n/a | Jun 12, 26 |
Control Empresarial De Capitales S.A. De C.V. Beneficial Owner (10%) | Acquired (grant/award) | +63.12M 30.2% of company | added 100% | 73.84M | n/a | Apr 28, 26 |
Pereira Brian Jg Director | Sold (automatic/other) | -502K 0.2% of company | n/a | n/a | $1.2M at $2.37 | Nov 13, 25 |
Pereira Brian Jg Director | Sold (automatic/other) | -255K 0.1% of company | sold 82% | 54K | $694K at $2.72 | Nov 12, 25 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Comparable names in biological products, (no diagnostic substances), closest in size first.
PROK is one of today's most active names, trading on unusually heavy volume (live price and day move above). Our scanner has fired 1 unusual-volume and momentum alert on PROK today, peaking at 3.3x its normal volume.
PROK last traded at $1.58, down 1.25% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
ProKidney Corp. Class A Ordinary Shares (PROK) is next expected to report earnings on Monday, November 9, 2026, about 33 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The PROK Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged PROK 64 times in the last 30 days.
PROK (ProKidney Corp. Class A Ordinary Shares) trades on XNAS, with a market cap of about $334M in the Biological Products, (No Diagnostic Substances) sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge PROK for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$PROK discussion
Sign in to ask a question or join the discussion.